논문 및 학회자료
|
Efficacy, Pharmacokinetic and Non-clinical Safety Profile of a novel A3AR antagonist, FM101, in the Treatment of Glaucoma by Oral administration (2017 WGC)
Admin │ 2017-12-29 HIT 794 |
|---|
|
|
| 이전글 | A3 adenosine receptor signaling regulates kupffer cell activation and NASH progr... |
|---|---|
| 다음글 | Preclinical characterization of FM101, a first-in class A3 adenosine receptor mo... |